Biogen Announces Webcast of Presentation at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference.Business Editors/Health/Medical Writers CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 24, 2003 Biogen, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BGEN BGen abbr. brigadier general ) announced today that its presentation at the CIBC World Markets CIBC World Markets is the investment banking division of the Canadian Imperial Bank of Commerce. It helps governments, large companies, and other large institutions obtain capital and credit and is a primary dealer in U.S. Treasury securities. Annual Biotechnology & Specialty Pharmaceuticals Conference will be webcast live on April 30, 2003. The live webcast begins at 9:00 AM (EDT) and is accessible through Biogen's homepage, www.Biogen.com. About Biogen Biogen is the world's oldest independent biotechnology company and a leader in biologics research, development and manufacturing. A pioneer in leading edge research in immunology, neurobiology Neurobiology Study of the development and function of the nervous system, with emphasis on how nerve cells generate and control behavior. The major goal of neurobiology is to explain at the molecular level how nerve cells differentiate and develop their and oncology, Biogen brings novel therapies to improve patients' lives around the world through its global marketing capabilities. For press releases and additional information about the company, please visit http://www.biogen.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion